1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Probiotic Agent: new trials by email Literature Review of Probiotic Agent trials Research Report on Probiotic Agent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Probiotic Use for Recovery Enhancement From Long COVID-19 Probiotic Agent, Placebo - Post-Acute COVID-19 Syndrome | Phase 2 | Completed | Rush University Medical Center | 194 | 2025-05-13 | 2026-08-07 |
| Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia Probiotic Agent, Dexamethasone - Immune Thrombocytopenia | Phase 2 | Unknown | Shandong University | 60 | 2017-01-01 | 2017-01-26 |
Post-Acute COVID-19 Syndrome (1) · Purpura, Thrombocytopenic, Idiopathic (1)
Rush University Medical Center (1) · Shandong University (1)
China (1) · United States (1)
Ming Hou (1)